Andrea Vismara
Fortuna: 14 M $ al 31/05/2026
Fortuna: 14 M $ al 31/05/2026
Andrea Vismara is Chief Executive Officer at Equita SIM SpA since 2017.
Mr. Vismara is Chief Executive Officer & Director at Equita Group SpA since 2008.
Mr. Vismara is Director at Blue Earth Diagnostics Ltd. Mr. Vismara is Director at Blue Earth Therapeutics Ltd. since 2022.
Mr. Vismara is Member at Commissione Nazionale per le Società e la Borsa.
Mr. Vismara is President at Equita Sim SpA (Investment Management) starting 2026.
Former roles include Vice Chairman at Assosim Associazione Italiana Intermediari Mobiliari and Chief Operating Officer at Credit Suisse First Boston Italia SpA from 2002 to 2003.
Education includes graduate degree from New York University and undergraduate degree from the University of Bocconi.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EQUITA GROUP SPA 3,94 % | 31/07/2025 | 2.101.734 ( 3,94 % ) | 14 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EQUITA GROUP S.P.A. | Director Ejecutivo | - |
Equita SIM SpA
Equita SIM SpA Investment Banks/BrokersFinance Provides brokerage services | Director Ejecutivo | 01/07/2017 |
Equita Sim SpA (Investment Management)
Equita Sim SpA (Investment Management) Investment ManagersFinance Equita Sim-IM is mainly focused on alternative, illiquid strategies in the Italian market with a focus on mid and small-caps. | Presidente | 01/01/2026 |
Commissione Nazionale per le Società e la Borsa
Commissione Nazionale per le Società e la Borsa General GovernmentGovernment Regulation of public savings | Corporate Officer/Principal | - |
Blue Earth Diagnostics Ltd.
Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Develops and commercialization molecular imaging technologies | Director/Miembro de la Junta | - |
Blue Earth Therapeutics Ltd.
Blue Earth Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops radiopharmaceuticals and oncology drugs | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Credit Suisse First Boston Italia SpA
Credit Suisse First Boston Italia SpA Investment Banks/BrokersFinance Provides securities, investment banking, insurance, investment trust, and management services | Director de Operaciones | 01/01/2003 |
Assosim Associazione Italiana Intermediari Mobiliari | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Equita SIM SpA
Equita SIM SpA Investment Banks/BrokersFinance Provides brokerage services | Finance |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bocconi
University of Bocconi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Credit Suisse First Boston Italia SpA
Credit Suisse First Boston Italia SpA Investment Banks/BrokersFinance Provides securities, investment banking, insurance, investment trust, and management services | Finance |
Commissione Nazionale per le Società e la Borsa
Commissione Nazionale per le Società e la Borsa General GovernmentGovernment Regulation of public savings | Government |
Assosim Associazione Italiana Intermediari Mobiliari | |
Equita Sim SpA (Investment Management)
Equita Sim SpA (Investment Management) Investment ManagersFinance Equita Sim-IM is mainly focused on alternative, illiquid strategies in the Italian market with a focus on mid and small-caps. | Finance |
Blue Earth Diagnostics Ltd.
Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Develops and commercialization molecular imaging technologies | Health Services |
Equita Group SpA
Equita Group SpA Investment Banks/BrokersFinance Operates as holding company whose subsidiary provides investment banking services | Finance |
Blue Earth Therapeutics Ltd.
Blue Earth Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops radiopharmaceuticals and oncology drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.